Charles G Mullighan

Title: Innovations by Charles G Mullighan

Introduction

Charles G Mullighan is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate protein activity. His work is essential in addressing various clinical conditions, including cancer.

Latest Patents

Mullighan holds 4 patents, with his latest focusing on substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs. These compounds are designed as modulators of cereblon protein activity. The patent outlines methods for creating these compounds, their pharmaceutical compositions, and their potential applications in treating disorders related to uncontrolled cellular proliferation, such as cancer. The compounds can selectively modulate the degradation of GSPT1 protein, acting as GSPT1 degraders.

Career Highlights

Mullighan is affiliated with St. Jude Children's Research Hospital, where he continues to advance his research and innovations. His work is pivotal in the development of new therapeutic strategies for challenging medical conditions.

Collaborations

Some of his notable coworkers include Fatemeh Keramatnia and Kevin McGowan, who contribute to the collaborative efforts in research and development at St. Jude Children's Research Hospital.

Conclusion

Charles G Mullighan's innovative work in the pharmaceutical field demonstrates his commitment to advancing medical science and improving treatment options for patients. His contributions are invaluable in the ongoing fight against diseases like cancer.